Visfatin: New marker of oxidative stress in preterm newborns

International Journal of Immunopathology and Pharmacology

Volumn 29, Issue 1, 2016, Pages 23-29

  Marseglia, Lucia ^a   D'Angelo, Gabriella ^a   Manti, Marta ^a   Aversa, Salvatore ^a   Fiamingo, Chiara ^a   Arrigo, Teresa ^a   Barberi, Ignazio ^a   Mamì, Carmelo ^a   Gitto, Eloisa ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

NAMPT visfatin; oxidative stress; oxygen; preterm newborns; resuscitation

Indexed keywords

BIOLOGICAL MARKER; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXYGEN; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN;

ARTICLE; BIRTH; CLINICAL ARTICLE; DELIVERY ROOM; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; GESTATIONAL AGE; HUMAN; NEWBORN; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PREMATURITY; PRIORITY JOURNAL; RESUSCITATION; BLOOD;

BIOMARKERS; CYTOKINES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATIVE STRESS;

EID: 84955573856     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/0394632015607952     Document Type: Article

References (42)

1. Floyd RA, (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB Journal 4: 2587-2597.
2. Abramov AY, Scorziello A, Duchen MR, (2007) Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. Journal of Neuroscience 27: 1129-1138.
3. Saugstad OD, (1988) Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatric Research 23: 143-150.
4. Rongvaux A, Shea RJ, Mulks MH, et al. (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. European Journal of Immunology 32 (11): 3225-3234.
5. Haider DG, Holzer G, Schaller G, et al. (2006) The adipokine visfatin is markedly elevated in obese children. Journal of Pediatric Gastroenterology and Nutrition 43: 548-549.
6. Bae SK, Kim SR, Kim JG, et al. (2006) Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Letters 580: 4105-4113.
7. Moschen AR, Kaser A, Enrich B, et al. (2007) Visfatin: An adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology 178: 1748-1758.
8. Ibáñez L, Sebastiani G, Lopez-Bermejo A, et al. (2008) Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: Relation to prenatal growth. Journal of Clinical Endocrinology and Metabolism 93: 2774-2778.
9. Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. (2007) Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 119: 1314-1318.
10. Wójcik M, Chmielewska-Kassassir M, Grzywnowicz K, et al. (2014) The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynologia Polska 65: 134-142.
11. Demir BC, Atalay MA, Ozerkan K, et al. (2013) Maternal adiponectin and visfatin concentrations in normal and complicated pregnancies. Clinical and Experimental Obstetrics & Gynecology 40: 261-267.
12. Karatas A, Tunçay Iikkent N, Ozlü T, et al. (2014) Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus. Gynecological Endocrinology 30 (5): 355-358.
13. Dessì A, Pravettoni C, Cesare Marincola F, et al. (2015) The biomarkers of fetal growth in intrauterine growth retardation and large for gestational age cases: From adipocytokines to a metabolomic all-in-one tool. Expert Review of Proteomics 12 (3): 309-16.
14. López-Bermejo A, de Zegher F, Díaz-Silva M, et al. (2008) Cord serum visfatin at term birth: Maternal smoking unmasks the relation to foetal growth. Clinical Endocrinology 68: 77-81.
15. Tambor V, Vajrychova M, Kacerovsky M, et al. (2015) Potential peripartum markers of infectious-inflammatory complications in spontaneous preterm birth. Biomed Research International 2015: 343501.
16. Cekmez F, Canpolat FE, Cetinkaya M, et al. (2011) Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. European Cytokine Network 22: 113-117.
17. Cekmez F, Canpolat FE, Pirgon O, et al. (2013) Adiponectin and visfatin levels in extremely low birth weight infants; they are also at risk for insulin resistance. European Review for Medical and Pharmacological Sciences 17 (4): 501-506.
18. Kattwinkel J, Perlman JM, Aziz K, et al. (2010) American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122: 909-919.
19. Perrone S, Bracci R, Buonocore G, (2002) New biomarkers of fetal-neonatal hypoxic stress. Acta Paediatrica 91: 135-138.
20. Halliwell B, (2006) Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiology 141: 312-322.
21. Marseglia L, D'Angelo G, Manti S, et al. (2014) Oxidative stress-mediated aging during the fetal and perinatal periods. Oxidative Medicine and Cellular Longevity 2014: 358375.
22. Saugstad OD, (1996) Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease. Acta Paediatrica 85: 1-4.
23. McCrea HJ, Ment LR, (2008) The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clinics in Perinatology 35: 777-792.
24. Haynes RL, Folkerth RD, Keefe RJ, et al. (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. Journal of Neuropathology & Experimental Neurology 62 (5): 441-450.
25. Saugstad OD, (2003) Bronchopulmonary dysplasia: Oxidative stress and antioxidants. Seminars in Neonatology 8 (1): 39-49.
26. Perrone S, Vezzosi P, Longini M, et al. (2009) Biomarkers of oxidative stress in babies at high risk for retinopathy of prematurity. Frontiers in Bioscience 1: 547-552.
27. Neu J, Walker WA, (2011) Necrotizing enterocolitis. New England Journal of Medicine 364 (3): 255-264.
28. Marseglia L, D'Angelo G, Manti S, et al. (2015) Oxidative stress-mediated damage in newborns with necrotizing enterocolitis: A possible role of melatonin. American Journal of Perinatology 32: 905-909.
29. Clyman RI, Saugstad OD, Mauray F, (1989) Reactive oxygen metabolites relax the lamb ductus arteriosus by stimulating prostaglandin production. Circulation Research 64 (1): 1-8.
30. Archer SL, Peterson D, Nelson DP, et al. (1989) Oxygen radicals and antioxidant enzymes alter pulmonary vascular reactivity in the rat lung. Journal of Applied Physiology 66 (1): 102-111.
31. Gitto E, Marseglia L, Manti S, et al. (2013) Protective role of melatonin in neonatal diseases. Oxidative Medicine and Cellular Longevity 2013: 980374.
32. Kattwinkel J, Niermeyer S, Nadkarni V, et al. (1999) ILCOR advisory statement: Resuscitation of the newly born infant. An advisory statement from the pediatric working group of the International Liaison Committee on Resuscitation. Circulation 99: 1927-1938.
33. Niermeyer S, Kattwinkel J, Van Reempts P, et al. (2000) International Guidelines for Neonatal Resuscitation: An excerpt from the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Contributors and Reviewers for the Neonatal Resuscitation Guidelines. Pediatrics 106 (3): e29.
34. Lefkowitz W, (2002) Oxygen and resuscitation: Beyond the myth. Pediatrics 109: 517-519.
35. Oita RC, Dudley F, Wilson S, et al. (2010) Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFB-dependent manner. Pflugers Archiv 459: 619-630.
36. Marseglia L, Manti S, D'Angelo G, et al. (2015) The role of visfatin in pregnancy, complications and procreation. Journal of Pediatric Biochemistry 5 (1): 1-6.
37. Malamitsi-Puchner A, Briana DD, Gourgiotis D, et al. (2007) Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatrica 96 (4): 526-529.
38. Mazaki-Tovi S, Vaisbuch E, Romero R, et al. (2010) Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate. Journal of Maternal-Fetal & Neonatal Medicine 23 (10): 1119-1128.
39. Moreno-Vinasco L, Quijada H, Sammani S, et al. (2014) Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury. American Journal of Respiratory Cell and Molecular Biology 51 (2): 223-228.
40. Zhang LQ, Heruth DP, Ye SQ, (2011) Nicotinamide phosphoribosyltransferase in human diseases. Journal of Bioanalysis & Biomedicine 7 (3): 13-25.
41. Jia SH, Li Y, Parodo J, et al. (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation 113 (9): 1318-1327.
42. Ye SQ, Simon BA, Maloney JP, et al. (2005) Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. American Journal of Respiratory and Critical Care Medicine 171 (4): 361-370.